Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.

Somatic cells reprogrammed into induced pluripotent stem cells (iPSCs) acquire features of human embryonic stem cells (hESCs) and thus represent a promising source for cellular therapy of debilitating diseases, such as age-related disorders. However, reprogrammed cell lines have been found to harbor...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Alessandro Prigione, Amir M Hossini, Björn Lichtner, Akdes Serin, Beatrix Fauler, Matthias Megges, Rudi Lurz, Hans Lehrach, Eugenia Makrantonaki, Christos C Zouboulis, James Adjaye
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2011
Materias:
R
Q
Acceso en línea:https://doaj.org/article/25f6d6f7499449069f6075831f408aaf
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:25f6d6f7499449069f6075831f408aaf
record_format dspace
spelling oai:doaj.org-article:25f6d6f7499449069f6075831f408aaf2021-11-18T07:34:24ZMitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.1932-620310.1371/journal.pone.0027352https://doaj.org/article/25f6d6f7499449069f6075831f408aaf2011-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/22110631/pdf/?tool=EBIhttps://doaj.org/toc/1932-6203Somatic cells reprogrammed into induced pluripotent stem cells (iPSCs) acquire features of human embryonic stem cells (hESCs) and thus represent a promising source for cellular therapy of debilitating diseases, such as age-related disorders. However, reprogrammed cell lines have been found to harbor various genomic alterations. In addition, we recently discovered that the mitochondrial DNA of human fibroblasts also undergoes random mutational events upon reprogramming. Aged somatic cells might possess high susceptibility to nuclear and mitochondrial genome instability. Hence, concerns over the oncogenic potential of reprogrammed cells due to the lack of genomic integrity may hinder the applicability of iPSC-based therapies for age-associated conditions. Here, we investigated whether aged reprogrammed cells harboring chromosomal abnormalities show resistance to apoptotic cell death or mitochondrial-associated oxidative stress, both hallmarks of cancer transformation. Four iPSC lines were generated from dermal fibroblasts derived from an 84-year-old woman, representing the oldest human donor so far reprogrammed to pluripotency. Despite the presence of karyotype aberrations, all aged-iPSCs were able to differentiate into neurons, re-establish telomerase activity, and reconfigure mitochondrial ultra-structure and functionality to a hESC-like state. Importantly, aged-iPSCs exhibited high sensitivity to drug-induced apoptosis and low levels of oxidative stress and DNA damage, in a similar fashion as iPSCs derived from young donors and hESCs. Thus, the occurrence of chromosomal abnormalities within aged reprogrammed cells might not be sufficient to over-ride the cellular surveillance machinery and induce malignant transformation through the alteration of mitochondrial-associated cell death. Taken together, we unveiled that cellular reprogramming is capable of reversing aging-related features in somatic cells from a very old subject, despite the presence of genomic alterations. Nevertheless, we believe it will be essential to develop reprogramming protocols capable of safeguarding the integrity of the genome of aged somatic cells, before employing iPSC-based therapy for age-associated disorders.Alessandro PrigioneAmir M HossiniBjörn LichtnerAkdes SerinBeatrix FaulerMatthias MeggesRudi LurzHans LehrachEugenia MakrantonakiChristos C ZouboulisJames AdjayePublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 6, Iss 11, p e27352 (2011)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Alessandro Prigione
Amir M Hossini
Björn Lichtner
Akdes Serin
Beatrix Fauler
Matthias Megges
Rudi Lurz
Hans Lehrach
Eugenia Makrantonaki
Christos C Zouboulis
James Adjaye
Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.
description Somatic cells reprogrammed into induced pluripotent stem cells (iPSCs) acquire features of human embryonic stem cells (hESCs) and thus represent a promising source for cellular therapy of debilitating diseases, such as age-related disorders. However, reprogrammed cell lines have been found to harbor various genomic alterations. In addition, we recently discovered that the mitochondrial DNA of human fibroblasts also undergoes random mutational events upon reprogramming. Aged somatic cells might possess high susceptibility to nuclear and mitochondrial genome instability. Hence, concerns over the oncogenic potential of reprogrammed cells due to the lack of genomic integrity may hinder the applicability of iPSC-based therapies for age-associated conditions. Here, we investigated whether aged reprogrammed cells harboring chromosomal abnormalities show resistance to apoptotic cell death or mitochondrial-associated oxidative stress, both hallmarks of cancer transformation. Four iPSC lines were generated from dermal fibroblasts derived from an 84-year-old woman, representing the oldest human donor so far reprogrammed to pluripotency. Despite the presence of karyotype aberrations, all aged-iPSCs were able to differentiate into neurons, re-establish telomerase activity, and reconfigure mitochondrial ultra-structure and functionality to a hESC-like state. Importantly, aged-iPSCs exhibited high sensitivity to drug-induced apoptosis and low levels of oxidative stress and DNA damage, in a similar fashion as iPSCs derived from young donors and hESCs. Thus, the occurrence of chromosomal abnormalities within aged reprogrammed cells might not be sufficient to over-ride the cellular surveillance machinery and induce malignant transformation through the alteration of mitochondrial-associated cell death. Taken together, we unveiled that cellular reprogramming is capable of reversing aging-related features in somatic cells from a very old subject, despite the presence of genomic alterations. Nevertheless, we believe it will be essential to develop reprogramming protocols capable of safeguarding the integrity of the genome of aged somatic cells, before employing iPSC-based therapy for age-associated disorders.
format article
author Alessandro Prigione
Amir M Hossini
Björn Lichtner
Akdes Serin
Beatrix Fauler
Matthias Megges
Rudi Lurz
Hans Lehrach
Eugenia Makrantonaki
Christos C Zouboulis
James Adjaye
author_facet Alessandro Prigione
Amir M Hossini
Björn Lichtner
Akdes Serin
Beatrix Fauler
Matthias Megges
Rudi Lurz
Hans Lehrach
Eugenia Makrantonaki
Christos C Zouboulis
James Adjaye
author_sort Alessandro Prigione
title Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.
title_short Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.
title_full Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.
title_fullStr Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.
title_full_unstemmed Mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived iPS cells harboring chromosomal aberrations.
title_sort mitochondrial-associated cell death mechanisms are reset to an embryonic-like state in aged donor-derived ips cells harboring chromosomal aberrations.
publisher Public Library of Science (PLoS)
publishDate 2011
url https://doaj.org/article/25f6d6f7499449069f6075831f408aaf
work_keys_str_mv AT alessandroprigione mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT amirmhossini mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT bjornlichtner mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT akdesserin mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT beatrixfauler mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT matthiasmegges mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT rudilurz mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT hanslehrach mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT eugeniamakrantonaki mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT christosczouboulis mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
AT jamesadjaye mitochondrialassociatedcelldeathmechanismsareresettoanembryoniclikestateinageddonorderivedipscellsharboringchromosomalaberrations
_version_ 1718423274085416960